DocDollars

Insmed, Inc.

NJ · United States · Reporting entity ID 100000461811

Total reported 2019–2025
$48.3M
#179 of 2,960 reporting companies — 0.1% of all reported industry payments
$11.2M in general payments across 108,867 records, plus $37.1M in research funding across 25,105 records.

How it breaks down

General payments $11,237,485
Research funding $37,108,718

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Insmed, Inc. reported $48.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #179 of 2,960 reporting companies. 77% of that was research funding and 23% general payments such as consulting, speaking, food and travel. 108,867 general payment records and 25,105 research records were filed.

Common questions about Insmed, Inc.

How much has Insmed, Inc. paid US doctors?

Insmed, Inc. reported $48,346,203 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $11,237,485 in general payments, $37,108,718 in research funding.

How does Insmed, Inc. rank among drug and device companies?

It ranks #179 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Insmed, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.